data

Eledon (NASDAQ: ELDN) reported preliminary results from the first six type 1 diabetes patients in an investigator-initiated islet transplant trial using tegoprubart …

The number of New Yorkers at risk of developing Type 2 diabetes more than doubled between 2011 and 2023, according to recent data released by the state Department of Health. …

Data source The data used in this study are from the Danish national health registers. All health data is reported when a patient among others is hospitalized, visits a GP, …

In this week’s issue of The Savvy Diabetic:  FDA Approves Kristy – Biosimilar to Novolog Dexcom Responds to Sensor Failures & More ‘Ozempic Teeth’ GLP-1 Side Effect Innovations in Preventing/Treating …

BORIS KOVATCHEV and PHD are the directors of the UVA Diabetes Technology Center. Virginia University Diabetes Researcher was discovered that data from continuous glucose monitors could predict nerves, eyes, and …

specialty please selectI'm not a medical professional.Allergy and immunologyanatomyanesthesiologybiostatisticsCardiac, thoracic, and vascular surgerycardiologycritical caredentaldermatologyDiabetes and endocrinologyemergency medical careepidemiology and public healthfamily medicineForensic medicineGastroenterologyGeneral medical treatmentgeneticsgeriatricsmedical policyhematologyHIV/AIDShospital-based medical careI'm not a …

Written by Francesco Guaracio and Phuong Nguyen HANOI – US technology companies have warned the Vietnamese government that a bill to tighten data protection rules and limit data transfers abroad …

NatureThe role of DNA damage in diabetic complications Mechanistic and clinical data suggest that DNA damage contributes to the development and progression of diabetic complications. 1 week ago

data All data utilized in this study were obtained from the UK Biobank, a comprehensive biomedical database containing extensive health information for 502,625 people living in the UK. Baseline assessments …

New data shows long-term use of an AID system powered by Dexcom CGM can safely maintain improvements in glycaemic outcomes for up to two years1. Real-world evidence demonstrates reduction in …